No Data
No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)
J.P. Morgan Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $512
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Express News | Vertex Pharmaceuticals Inc : JP Morgan Raises Target Price to $512 From $500
Top 10 S&P 500 Performers of 2025 All Returned Over 20% as the Broader Index Struggles
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today